30 years of historical data (1996–2025) · Healthcare · Medical - Care Facilities
Percentile shows where the current value sits in 30-year historical distribution. Sparklines show 5-year trend.
Price-based multiples — how expensive the stock is relative to earnings, sales, book value, and cash flow
Universal Health Services, Inc. trades at 6.1x earnings, 50% below its 5-year average of 12.3x, sitting at the 0th percentile of its historical range. Compared to the Healthcare sector median P/E of 22.1x, the stock trades at a discount of 72%. On a free-cash-flow basis, the stock trades at 10.4x P/FCF, 89% below the 5-year average of 94.9x.
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Market Cap | $8.8B | $14.1B | $12.2B | $10.7B | $10.4B | $10.9B | $11.8B | $12.8B | $10.9B | $10.9B | $10.5B |
| Enterprise Value | $14.2B | $19.4B | $17.0B | $15.9B | $15.6B | $15.3B | $14.7B | $17.0B | $14.8B | $14.9B | $14.6B |
| P/E Ratio → | 6.11 | 9.44 | 10.67 | 14.90 | 15.41 | 10.97 | 12.51 | 15.71 | 14.01 | 14.51 | 14.90 |
| P/S Ratio | 0.51 | 0.81 | 0.77 | 0.75 | 0.78 | 0.86 | 1.02 | 1.12 | 1.01 | 1.05 | 1.07 |
| P/B Ratio | 1.23 | 1.90 | 1.80 | 1.72 | 1.74 | 1.75 | 1.84 | 2.29 | 2.00 | 2.16 | 2.27 |
| P/FCF | 10.40 | 16.55 | 10.84 | 20.37 | 39.70 | 387.06 | 7.24 | 16.48 | 20.65 | 19.05 | 78.54 |
| P/OCF | 4.74 | 7.54 | 5.89 | 8.43 | 10.44 | 12.28 | 4.99 | 8.88 | 8.15 | 9.23 | 8.12 |
P/E links to full P/E history page with 30-year chart
Enterprise-value multiples — capital-structure-neutral measures of total business value
Universal Health Services, Inc.'s enterprise value stands at 5.4x EBITDA, 35% below its 5-year average of 8.4x. The Healthcare sector median is 14.2x, placing the stock at a 62% discount on an enterprise-value basis.
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| EV / Revenue | — | 1.12 | 1.07 | 1.12 | 1.16 | 1.21 | 1.28 | 1.50 | 1.38 | 1.43 | 1.49 |
| EV / EBITDA | 5.44 | 7.43 | 7.51 | 9.14 | 9.82 | 8.07 | 7.89 | 9.98 | 9.10 | 8.61 | 8.58 |
| EV / EBIT | 7.12 | 9.14 | 10.12 | 13.89 | 15.68 | 11.11 | 10.85 | 13.85 | 12.54 | 11.73 | 11.52 |
| EV / FCF | — | 22.87 | 15.14 | 30.37 | 59.42 | 545.57 | 9.06 | 21.97 | 28.00 | 25.97 | 109.32 |
Margins and return-on-capital ratios measuring operating efficiency
Universal Health Services, Inc. earns an operating margin of 11.5%. Operating margins have expanded from 8.2% to 11.5% over the past 3 years, signaling improving operational efficiency. ROE of 21.0% indicates solid capital efficiency. ROIC of 12.3% represents solid returns on invested capital.
Full margin charts and quarterly trend are on the Earnings History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 90.4% | 90.4% | 90.0% | 89.3% | 89.0% | 88.7% | 88.9% | 89.0% | 89.2% | 89.4% | 89.4% |
| Operating Margin | 11.5% | 11.5% | 10.6% | 8.2% | 7.5% | 10.8% | 11.8% | 10.7% | 10.9% | 12.3% | 13.1% |
| Net Profit Margin | 8.6% | 8.6% | 7.2% | 5.0% | 5.0% | 7.8% | 8.2% | 7.2% | 7.2% | 7.2% | 7.2% |
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ROE | 21.0% | 21.0% | 17.6% | 11.8% | 11.1% | 15.7% | 15.7% | 14.7% | 14.8% | 15.6% | 15.3% |
| ROA | 9.8% | 9.8% | 8.0% | 5.2% | 5.1% | 7.5% | 7.5% | 7.1% | 7.1% | 7.1% | 7.0% |
| ROIC | 12.3% | 12.3% | 10.9% | 7.8% | 6.9% | 10.2% | 10.6% | 9.5% | 9.6% | 10.8% | 11.6% |
| ROCE | 16.0% | 16.0% | 13.9% | 10.0% | 8.8% | 12.3% | 12.9% | 12.2% | 12.5% | 14.3% | 14.6% |
Solvency and debt-coverage ratios — lower is generally safer
Universal Health Services, Inc. carries a Debt/EBITDA ratio of 2.1x, which is manageable (34% below the sector average of 3.2x). Net debt stands at $5.4B ($5.5B total debt minus $138M cash). Interest coverage of 13.5x signals virtually no risk of debt distress — earnings comfortably cover interest obligations.
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt / Equity | 0.74 | 0.74 | 0.73 | 0.87 | 0.88 | 0.74 | 0.65 | 0.77 | 0.73 | 0.80 | 0.90 |
| Debt / EBITDA | 2.11 | 2.11 | 2.19 | 3.08 | 3.32 | 2.40 | 2.24 | 2.53 | 2.46 | 2.34 | 2.44 |
| Net Debt / Equity | — | 0.72 | 0.71 | 0.85 | 0.87 | 0.72 | 0.46 | 0.76 | 0.71 | 0.78 | 0.89 |
| Net Debt / EBITDA | 2.06 | 2.06 | 2.13 | 3.01 | 3.26 | 2.34 | 1.59 | 2.49 | 2.39 | 2.29 | 2.42 |
| Debt / FCF | — | 6.32 | 4.30 | 10.00 | 19.73 | 158.51 | 1.83 | 5.48 | 7.36 | 6.92 | 30.79 |
| Interest Coverage | 13.51 | 13.51 | 8.96 | 5.53 | 7.80 | 16.15 | 12.45 | 7.55 | 7.63 | 8.88 | 10.84 |
Short-term solvency ratios and asset-utilisation metrics
A current ratio of 1.05x means Universal Health Services, Inc. can comfortably meet its short-term obligations, though there is limited excess liquidity. The current ratio has declined from 1.40x to 1.05x over the past 3 years.
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.05 | 1.05 | 1.27 | 1.40 | 1.33 | 1.14 | 1.32 | 1.23 | 1.34 | 0.97 | 1.28 |
| Quick Ratio | 0.98 | 0.98 | 1.17 | 1.29 | 1.21 | 1.04 | 1.25 | 1.12 | 1.24 | 0.90 | 1.18 |
| Cash Ratio | 0.04 | 0.04 | 0.06 | 0.06 | 0.05 | 0.06 | 0.49 | 0.04 | 0.07 | 0.04 | 0.03 |
| Asset Turnover | — | 1.09 | 1.09 | 1.02 | 0.99 | 0.97 | 0.86 | 0.98 | 0.96 | 0.97 | 0.95 |
| Inventory Turnover | 7.15 | 7.15 | 7.19 | 7.06 | 6.75 | 6.90 | 6.76 | 7.83 | 7.89 | 8.12 | 8.23 |
| Days Sales Outstanding | — | 54.70 | 50.22 | 57.20 | 54.96 | 50.43 | 54.60 | 50.07 | 51.16 | 52.63 | 53.80 |
Earnings, FCF, buyback, and dividend yields — total returns to shareholders
Universal Health Services, Inc. returns 11.5% to shareholders annually — split between a 0.6% dividend yield and 11.0% buyback yield. The payout ratio of 3.4% is conservative, leaving significant room for dividend growth or reinvestment. The earnings yield of 16.4% (inverse of P/E) provides a useful comparison to bond yields when assessing the stock's relative attractiveness to fixed income.
Full dividend history and growth charts are on the Dividend History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Dividend Yield | 0.6% | 0.4% | 0.4% | 0.5% | 0.6% | 0.6% | 0.1% | 0.4% | 0.3% | 0.4% | 0.4% |
| Payout Ratio | 3.4% | 3.4% | 4.7% | 7.7% | 8.7% | 6.6% | 1.8% | 6.5% | 4.8% | 5.1% | 5.5% |
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Earnings Yield | 16.4% | 10.6% | 9.4% | 6.7% | 6.5% | 9.1% | 8.0% | 6.4% | 7.1% | 6.9% | 6.7% |
| FCF Yield | 9.6% | 6.0% | 9.2% | 4.9% | 2.5% | 0.3% | 13.8% | 6.1% | 4.8% | 5.2% | 1.3% |
| Buyback Yield | 11.0% | 6.9% | 5.5% | 5.1% | 8.0% | 11.3% | 1.8% | 6.0% | 3.6% | 3.3% | 3.4% |
| Total Shareholder Yield | 11.5% | 7.3% | 5.9% | 5.6% | 8.6% | 11.9% | 1.9% | 6.4% | 4.0% | 3.7% | 3.7% |
| Shares Outstanding | — | $64M | $68M | $70M | $74M | $84M | $86M | $89M | $94M | $96M | $98M |
Compare UHS with 10 similar companies in its peer group
| Company | Market Cap | P/E | EV/EBITDA | P/FCF | Gross Margin | Op Margin | ROE | ROIC | Debt/EBITDA |
|---|---|---|---|---|---|---|---|---|---|
| $9B | 6.1 | 5.4 | 10.4 | 90.4% | 11.5% | 21.0% | 12.3% | 2.1 | |
| $84B | 13.2 | 8.6 | 10.9 | 41.5% | 15.8% | — | 19.9% | 3.2 | |
| $15B | 11.1 | 5.9 | 6.0 | 82.3% | 16.1% | 16.1% | 13.2% | 3.1 | |
| $426M | 0.8 | — | 2.0 | 8.7% | -79.4% | — | -70.1% | — | |
| $9B | 26.3 | 23.5 | 24.2 | 13.7% | 8.6% | 16.9% | 7.0% | 7.7 | |
| $2B | -2.0 | 8.3 | — | 17.6% | 11.7% | -41.4% | 5.9% | 4.6 | |
| $2B | 14.0 | 12.1 | 5.4 | 11.5% | 6.1% | 7.3% | 4.8% | 7.8 | |
| $2B | -23.9 | 10.1 | 9.7 | 23.1% | 11.8% | -2.2% | 4.1% | 7.1 | |
| $964M | 44.6 | 13.2 | 15.8 | 20.1% | 10.3% | 2.0% | 5.6% | 4.1 | |
| $570M | -1.9 | 1.2 | — | 99.2% | 33.9% | -27.3% | 11.2% | 0.1 | |
| $364B | 30.3 | 17.9 | 22.6 | 18.5% | 4.2% | 11.8% | 9.2% | 3.4 | |
| Healthcare Median | — | 22.1 | 14.2 | 18.5 | 63.9% | -4.3% | -32.6% | -11.6% | 3.2 |
Peer selection based on competitive and market overlap. Compare multiple stocks →
Includes 30+ ratios · 30 years · Updated daily
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
See how regular investing compounds over time.
Compare growth, multiples, and margins vs sector.
Quick answers to the most common questions about buying UHS stock.
Universal Health Services, Inc.'s current P/E ratio is 6.1x. The historical average is 16.0x.
Universal Health Services, Inc.'s current EV/EBITDA is 5.4x. This enterprise value multiple compares the company's total value (equity + debt - cash) to its EBITDA. The historical average is 8.1x.
Universal Health Services, Inc.'s return on equity (ROE) is 21.0%. This is above the typical threshold of 15-20% considered good for most companies. The historical average is 14.5%.
Based on historical data, Universal Health Services, Inc. is trading at a P/E of 6.1x. Compare with industry peers and growth rates for a complete picture.
Universal Health Services, Inc.'s current dividend yield is 0.56% with a payout ratio of 3.4%.
Universal Health Services, Inc. has 90.4% gross margin and 11.5% operating margin. Operating margin between 10-20% is typical for established companies.
Universal Health Services, Inc.'s Debt/EBITDA ratio is 2.1x, indicating moderate leverage. A ratio between 2-4x is manageable but warrants monitoring.